The renin-angiotensin system plays a critical role in sodium and fluid homeostasis. Genetic or acquired alterations in the expression of components of this system are strongly implicated in The renin-angiotensin system (RAS) is one of the primary physiological regulators of sodium and fluid balance (1). The RAS regulates body-fluid homeostasis through several distinct mechanisms-including effects on hemodynamics and vascular tone, direct stimulation of sodium reabsorption by the kidney, and stimulation of aldosterone production by the adrenal glands (2). The propensity of the RAS to cause elevated blood pressure was first recognized in acquired disorders such as renovascular hypertension (3), and alterations in the activity of this system have been strongly implicated in the pathogenesis of essential hypertension. For example, variations in genes encoding renin (4, 5), angiotensinogen (6, 7), angiotensinconverting enzyme (8, 9) , and angiotensin receptors (10) (11) (12) have been associated with hypertension in human populations and in animal models of sodium-sensitive hypertension.
gotes exhibited a reduction in renal AT1 receptor-specific binding to "50% of wild-type [AgtrIA(+/+)] levels. Pressor responses to infused angiotensin II were virtually absent in AgtrlA(-/-) mice and were qualitatively altered in AghIA(+/-) heterozygotes. Compared with wild-type controls, systolic blood pressure measured by tail cuff sphygmomanometer was reduced by 12 mmHg (1 mmHg = 133 Pa) in AgtrlA(+/-) mice and by 24 mmHg in AgtrlA(-/-) mice.
Similar differences in blood pressure between the groups were seen when intraarterial pressures were measured by carotid cannulation. These studies demonstrate that type 1A angiotensin II receptor function is required for vascular and hemodynamic responses to angiotensin II and that altered expression of the AgtrlA gene has marked effects on blood pressures.
The renin-angiotensin system (RAS) is one of the primary physiological regulators of sodium and fluid balance (1) . The RAS regulates body-fluid homeostasis through several distinct mechanisms-including effects on hemodynamics and vascular tone, direct stimulation of sodium reabsorption by the kidney, and stimulation of aldosterone production by the adrenal glands (2) . The propensity of the RAS to cause elevated blood pressure was first recognized in acquired disorders such as renovascular hypertension (3) , and alterations in the activity of this system have been strongly implicated in the pathogenesis of essential hypertension. For example, variations in genes encoding renin (4, 5) , angiotensinogen (6, 7) , angiotensinconverting enzyme (8, 9) , and angiotensin receptors (10) (11) (12) have been associated with hypertension in human populations and in animal models of sodium-sensitive hypertension.
The major biologically active product of the RAS is the multifunctional peptide angiotensin 11 (1) . The physiological effects of angiotensin II are elicited through binding to specific cell-surface receptors (13) . Angiotensin II receptors belong to the large family of rhodopsin-like G protein-associated receptors and have been divided into two pharmacologically distinct types designated type 1 (AT1) and type 2 (AT2) (13) (14) (15) (16) (17) . AT1
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
receptors are thought to mediate the known functions of angiotensin 11 (13) (14) (15) ; they are defined pharmacologically by their high-affinity binding to the nonpeptide antagonist losartan (Dup 573). AT2 receptors exhibit high-affinity binding to the antagonists PD 123177 and CGP 42112, but the physiological function of and signaling mechanisms used by AT2 receptors are not known (13, 16, 17) .
Among the AT1 receptors, two subtypes ATlA and ATlB have been identified in human, rat, and mouse (18) (19) (20) (21) . These receptors are products of separate genes, share substantial sequence homology, and have wide tissue distributions. The ATlA receptor seems to predominate in most tissues except the adrenal gland and the anterior pituitary (18) (19) (20) (21) (22) (23) (24) (25) (26) , and expression of ATlA and ATlB receptors may be differentially regulated in the heart and the adrenals (22, 25, 26) . This differential tissue distribution and regulation of AT1 receptor subtypes may serve to modulate the biological effects of angiotensin II. However, due to the lack of discriminatory pharmacological antagonists, the individual functions of the two AT1 receptor subtypes (A and B) have not been defined.
Associations between alterations in AT1 receptor-encoding genes and hypertension have been identified in previous studies. For example, Deng and associates (10, 11) found that the AT1l receptor gene is in a region of rat chromosome 2 that has an effect on blood pressure in both Lyon and Dahl rats. The same group found no association between the ATlA receptor locus and hypertension in Dahl rats (27) . However, in a recent study in humans with essential hypertension, Bonnardeaux et at (12) identified an association between several ATIA receptor-encoding gene polymorphisms and hypertension. Thus, there are data from humans and rats suggesting that AT1 receptor genes might play a role in the pathogenesis of hypertension. In the present study, we have used gene targeting to determine which distinct physiological functions are specific to the ATlA receptor gene. We have also defined the potential for naturally occurring mutations of the ATlA receptor gene to affect the regulation of blood pressures.
MATERIALS AND METHODS
Gene Targeting. The gene encoding the AT1A receptor (AgtrJA) was isolated from an E14TG2a embryonal stem cell (28) genomic library, using a probe generated by PCR from primers synthesized on the basis of published sequences for the rat ATlA receptor (15) . A restriction map of the genomic clone is shown in Fig. 1A . To construct the targeting vector, shown in Fig. 1B resistance cassette (neo) from pMClneopolA (29) . The Herpes simplex thymidine kinase gene from pMClTK was inserted downstream of the 3' homology arm. The embryonic stem cell line BK4, a subclone isolated from E14TG2a, was electroporated with the linearized targeting vector followed by positivenegative selection (29) with G418 at 0.15 mg/ml and 2 ,uM ganciclovir. G418/ganciclovir-resistant colonies were expanded and analyzed by PCR (30) . Targeted embryonal stem cell lines were identified by the presence of a 1.7-kb PCR product using the PCR primers indicated by the arrows in Fig.  1C .
Blastocyst Injection and Mouse Genotype Analysis. Targeted embryonal stem cell lines containing the disrupted AgtrlA gene were injected into blastocysts to generate male chimeras, which were then mated with inbred females of strain C57BL/6J. F1 progeny heterozygous for the disrupted AgtrlA gene were interbred to generate F2 animals. To determine animal genotypes, genomic DNA was purified from tail biopsies, digested with BamHI, and analyzed by Southern blot analysis. Incorporation of the targeting vector into the locus introduces another BamHI site, so that the targeted allele can be identified by the presence of a diagnostic 3.8-kb BamHI fragment using the probe shown in Fig. 1C . A representative autoradiogram of a Southern blot analysis of tail DNA samples is shown in Fig. 1D .
[Sarl,Ile8]Angiotensin II Receptor Autoradiography. Kidneys were removed from anesthetized AgtrlA(+/+), (+/-), and (-/-) mice, placed in liquid plastic (OCT compound), and frozen in isobutane chilled by liquid nitrogen. Twentymicrometer sections were thaw-mounted on glass slides, and receptor autoradiography was done as described (31) Blood Pressure Measurements. Systolic pressure was measured in conscious mice using a computerized noninvasive tail cuff system that determines tail blood flow using a photoelectric sensor. The validity of this system and its correlation with intraarterial pressure measurements have been demonstrated (32) . Consistent with these previous studies, there was a significant linear correlation between blood pressure measured by tail cuff and by intraarterial catheter within our present experiments (correlation coefficient = 0.68; P < 0.0001). All blood pressure determinations were obtained by an investigator (C.F.B.) who was unaware of the genotypes of the animals being tested. Mice were trained to the tail cuff apparatus for at least 5 days. Blood pressures were then measured and recorded for 5 consecutive days, and a mean value was generated for each individual mouse. To obtain intraarterial pressures, carotid artery catheters were placed as described above. After the animals had recovered from anesthesia, they were maintained in a quiet environment, unrestrained and conscious, and blood pressure was recorded continuously over a period of 30 min. Based on the blood pressure recordings during this period, a mean value for systolic pressure was calculated by using the Windaq software package (Dataq Instruments).
Statistical Analysis. Data are presented as the means ± SEMs. Statistical significance was assessed by using analysis of variance and the unpaired t test.
RESULTS AND DISCUSSION
Gene Targeting. After introduction of the targeting plasmid (Fig. 1B) into embryonic stem cells by electroporation, colonies resistant to G418 and ganciclovir (29) were screened for homologous recombinants by PCR. Targeting was confirmed by Southern blot analysis using the probe shown in Fig. 1C . The targeting frequency was -1 per 100 doubly resistant colonies. Four male chimeras that were mated with C57BL/6 females transmitted the disrupted AgtrlA gene to their progeny producing (129 x C57BL/6)F1 mice heterozygous (+/-) for the mutation. These F1(+/-) heterozygotes were interbred to generate F2 mice that were homozygous for the mutant ATIA receptor gene.
Generation of Mice That Lack ATlA Receptors. Previous studies have suggested that the RAS plays a role in fetal development and organogenesis. This hypothesis is based, in part, on the observation that there is programmed expression of both AT1 and AT2 receptors within the developing fetus (33) (34) (35) (36) Fig. 2 shows that both AT1 receptorand AT2 receptor-specific binding could easily be detected in the kidneys of (+/+) animals: AT1 receptor binding (Fig. 2C) is distributed in cortical areas and around glomeruli; AT2 receptor binding (Fig. 2D ) is also present in the cortex but extends into the medulla with a vascular and/or tubular distribution. In the kidneys of AgtrlA(-/-) mice, total angiotensin II binding (Fig. 2F) is significantly reduced compared with controls ( Fig. 2A) and consists almost entirely of AT2 receptor-specific binding (Fig. 2I) . AT1 receptor-specific binding (Fig. 2H) is virtually absent in AgtrlA(-/-) mice, con-1+7+1 l firming the efficacy of the gene disruption and suggesting that most AT1 receptor-specific binding in the kidney is due to binding to ATlA receptors. Heterozygous (+/-) mice have levels of AT1 receptor-specific binding intermediate between the (-/-) and (+/+) animals (data not shown); thus, absence of a singleAgtrlA allele results in a substantial reduction in the binding level that is not compensated through other regulatory mechanisms.
In Vivo Responses to Angiotensin II. To determine the effects of altered ATlA receptor expression on in vivo responses to angiotensin II, we infused angiotensin II peptide i.v.
to conscious mice (Fig. 3) . In (+/+) mice, an i.v. 10 jig/kg bolus of angiotensin II causes an initial increase in blood pressure that peaks at 20 sec followed by a delayed depressor response. Despite the reduced level of receptor expression in AgtrlA(+/-) mice, the magnitudes of the peak pressor and depressor effects of angiotensin II seen in these heterozygotes resembled those in AgtrlA(+/+) animals. However, the pattern of the response was qualitatively different: the positive pressor response was short-lived in the AgtrlA(+/-) mice compared with controls, and the depressor response was clearly evident within 400 sec inAgtrlA(+ /-) mice compared with >500 sec in AgtrlA(+/+) animals. This result suggests that the character of the pressor-depressor responses mediated by angiotensin II can be altered when receptor density is reduced. Infusions of angiotensin II had virtually no effect on the blood pressures ofAgtrlA(-/-) mice, demonstrating that this acute hemodynamic response to angiotensin II requires ATlA receptors.
Blood Pressures inAgtrlA Mutant Mice. We determined the steady-state effects of changes in ATlA receptor expression on blood pressures in F2 animals between 8 and 12 weeks of age. The three genotypes differed significantly (Fig. 4 Even a partial reduction in expression has a demonstrable effect, and this effect is seen in animals with all of their homeostatic mechanisms otherwise intact.
Exclusion of the Effects of Linked Genes. To be certain that the differences in blood pressures observed in AgtrlA mutant mice do not depend on genes linked to the AgtrlA locus that differ in mouse strains 129 and C57BL/6, we also examined blood pressures in F1(+/+) and F2(+/-) mice. These animals differ systematically in having either a wild-type or a mutant ATIA gene derived from strain 129, but they do not differ systematically in any other genes, linked or unlinked to the AgtrlA locus. Blood pressures were measured by tail cuff sphygmomanometer. Systolic blood pressures in the F2(+/-) mice (n = 7) were significantly lower than in the F1(+/+) animals (n = 9) [103 ± 3 mmHg versus 111 ± 6 mmHg; P = 0.037]. Thus, the effects of the AgtrlA mutation on blood pressure are independent of any other genetic differences between strain 129 and C57BL/6 mice, linked or unlinked to the AgtrlA locus.
Conclusions. In these studies, we have examined the physiological functions of the ATlA receptor for angiotensin II using gene targeting. We find that the ATjA receptor is not necessary for normal development and survival and that the heart, kidney, and vascular system appear normal in the absence of ATlA receptors. ATIA receptors are, however, required for both the pressor and depressor hemodynamic responses to exogenous angiotensin II infusion, and virtually all of the AT1 receptor-specific angiotensin II binding in the kidney is due to ATlA receptors. AgtrlA(+/-) heterozygotes have reduced levels of receptor expression that is not compensated through other regulatory mechanisms. The reduced receptor density in AgtrlA(+/-) mice results in a qualitative alteration in the pressor response to angiotensin II and is associated with a significant reduction in resting blood pressure. Blood pressure is further reduced inAgtrlA(-/-) mice. These studies demonstrate the importance of the AgtrlA gene in regulating blood pressure in mice and suggest that variants of the humanAGTRIA gene, which alter its level of expression, may likewise affect blood pressures.
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